Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Study finds gene for fatal heart condition:

This article was originally published in Clinica

Executive Summary

Israeli researchers have identified a gene that could lead to improvements in screening for polymorphic ventricular tachycardia, a heart condition that can result in sudden death in young children. A simple mutation in the Calsequestrin 2 (CASQ2) gene impairs the ability of the CASQ2 protein to attract and release calcium ions on demand, which is vital for normal contraction and relaxation of the heart, report researchers led by Dr Nili Avidan, of the Weizmann Institute of Science, in Rehovot.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065102

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel